Abstract: A combustor comprising a dome wall, an annular liner, a combustion chamber, a set of fuel cups, and a set of dilution passages for each fuel cup of the set of fuel cups. The set of fuel cups circumferentially spaced along the dome wall relative to the combustor centerline. The set of dilution passages terminating in a plurality of slots spaced about the corresponding fuel cup in the set of fuel cups.

Abstract: A gas turbine engine includes a compressor section, a combustor section, and a turbine section in fore-to-aft serial flow arrangement and defines an engine centerline. The combustor section includes a combustor liner at least partially defining a combustor chamber and a dome wall, coupled to the combustor liner, and defining a forward end of the combustion chamber. A fuel nozzle is located on the dome wall and fluidly coupled to the combustion chamber. A first set of compressed air openings emit compressed air into the combustion chamber along a first flow path and a second set of compressed air openings emit compressed air into the combustion chamber along a second flow path. The first and second flow paths intersect at an intersection point to form a sheet of air.

Abstract: A combustor for a gas turbine engine. The combustor having a dome wall, a set of fuel cups, an inner liner, an outer liner, and a set of dilution passages. The dome wall, the inner liner, and the outer liner, together, at least partially defining a combustion chamber. The set of dilution passages terminating in a plurality of dilution holes arranged in a dilution hole arrangement provided in at least one of the inner liner or the outer liner. The dilution hole arrangement having at least a first subset of dilution holes arranged along a first leg and a second subset of dilution holes arranged along a second leg.

Abstract: Provided herein are anti-TREM1 antibodies and related methods of making and using anti-TREM1 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an anti-TREM1 antibody or antigen binding fragment thereof.

Abstract: A combustor comprising a dome wall, a combustor liner extending from the dome wall, and a combustion chamber at least partially defined by the dome wall and the combustor liner. A set of fuel cups are arranged along the dome wall. A set of dilution passages extend through the dome wall or the combustor liner to direct air into the combustion chamber, wherein a dilution passage of the set of dilution passages includes an inlet, an outlet, and a passageway.

Abstract: Provided herein are anti-TREM2 antibodies and related methods of making and using anti-TREM2 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an anti-TREM2 antibody or antigen binding fragment thereof.

Abstract: Provided herein are anti-TREM2 antibodies and related methods of making and using anti-TREM2 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an anti-TREM2 antibody or antigen binding fragment thereof.

Abstract: Provided herein are anti-TREM2 antibodies and related methods of making and using anti-TREM2 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, using an anti-TREM2 antibody or antigen binding fragment thereof.

Abstract: Provided herein are anti-TREM1 antibodies and related methods of making and using anti-TREM1 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an anti-TREM1 antibody or antigen binding fragment thereof.

Abstract: Provided herein are anti-TREM1 antibodies and related methods of making and using anti-TREM1 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an anti-TREM1 antibody or antigen binding fragment thereof.

Abstract: Provided herein are anti-TREM1 antibodies and related methods of making and using anti-TREM1 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an anti-TREM1 antibody or antigen binding fragment thereof.

Abstract: Provided herein are anti-TREM2 antibodies and related methods of making and using anti-TREM2 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an anti-TREM2 antibody or antigen binding fragment thereof.

Abstract: Provided herein are anti-TREM2 antibodies and related methods of making and using anti-TREM2 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an anti-TREM2 antibody or antigen binding fragment thereof.

Abstract: Provided herein are anti-TREM2 antibodies and related methods of making and using anti-TREM2 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an anti-TREM2 antibody or antigen binding fragment thereof.